Subscribe To
Palisade bio further strengthens balance sheet with early exercise of warrants resulting in cash proceeds of $4.9 million
Proceeds expected to extend cash runway to fund operations into the second half of 2024 Carlsbad, CA, Jan. 10, 2023 (GLOBE NEWSWIRE) — Palisade Bio,...
January 10, 2023, 1:35 pm
Alnylam pharmaceuticals starts 2023 with in-line revenue and a full slate of clinical read-outs
Alnylam's fourth quarter product revenue was more or less as expected, with a faster/better-than-expected pace of switching between Onpattro and Amvut...
January 10, 2023, 12:59 pm
Glenmark pharmaceuticals launches congestive heart failure injection in united states
Bumetanide is used to reduce extra fluid in the body (edema) caused by conditions such as congestive heart failure, liver disease, and kidney disease....
January 10, 2023, 7:29 am
Santhera enters into chf 5 million share exchange agreement
Santhera pharmaceuticals (SIX: SANN) announces that through a share exchange it will receive the equiva...
January 10, 2023, 6:14 am
Actinium pharmaceuticals: prep for february
Actinium pharmaceuticals is delivering the goods on a deep pipeline of therapeutics. It has deepened it...
January 10, 2023, 4:23 am
Medicinova receives a notice of allowance for a new patent covering mn-001 and mn-002 for the treatment of hypertriglyceridemia, hypercholesterolemia, and hyperlipoproteinemia in brazil
LA JOLLA, Calif., Jan. 09, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company trad...
January 10, 2023, 3:00 am
Jnj could have started a bearish movement to end wave ii correction.
Johnson & Johnson (JNJ) is an American multinational corporation founded in 1886 that develops medical devices, ...
January 10, 2023, 1:14 am
Ranking the top 10 pharmaceuticals by pipeline
The pipeline is the heart of a drug discovery company. As such, analyzing the health of a pipeline can lead to suggestions about future performance....
January 9, 2023, 11:44 pm
Regeneron pharmaceuticals, inc. (regn) 41st annual j.p. morgan healthcare conference (transcript)
Regeneron pharmaceuticals, Inc. (NASDAQ:REGN ) 41st Annual J.P. Morgan Healthcare Conference January 9,...
January 9, 2023, 11:39 pm
Royalty pharma: an attractive business model but an uncertain outcome for vertex's cf royalties
Royalty Pharma purchases royalties on pharmaceutical products. Diversification provides some protection...
January 9, 2023, 11:13 pm
pharmaceutical stock sinks on sales forecast
BioCryst pharmaceuticals Inc (NASDAQ:BCRX) stock is sinking today, down 11.6% at $10.45 at last glance,...
January 9, 2023, 3:10 pm
Vertex pharmaceuticals incorporated (vrtx) 41st annual j.p. morgan healthcare conference - (transcript)
Vertex pharmaceuticals Incorporated (NASDAQ:VRTX ) 41st Annual J.P. Morgan Healthcare Conference Call J...
January 9, 2023, 1:04 pm
Innovation pharmaceuticals announces bt beamedical technologies and shina systems ltd. enter into a definitive strategic development agreement
Multiyear Development and Support Agreement Lays the Foundation for the Realization of an Advanced Software Suite to Enable Revolutionary Treatments o...
January 9, 2023, 12:30 pm
Rvl pharmaceuticals plc announces preliminary fourth quarter sequential growth of 21% and full year 2022 upneeq® net product sales
— Expects fourth quarter 2022 preliminary UPNEEQ net product sales of approximately $12.1 million, representing an increase of 21% over the third qu...
January 9, 2023, 11:50 am
Pharma stock falls amid workforce reduction plans
Emergent BioSolutions Inc (NYSE:EBS) is in the news today, after the pharmaceutical company announced i...
January 9, 2023, 10:30 am
Teva pharmaceutical industries ltd. (teva) stock jumps 5.5%: will it continue to soar?
Teva pharmaceutical Industries Ltd. (TEVA) witnessed a jump in share price last session on above-averag...
January 9, 2023, 9:47 am
Royalty pharma agrees to buy ionis pharma royalties for $1.125 bln
Royalty Pharma Plc RPRX, -1.42% said Monday it agreed to pay up to $1.125 billion for drug royalties owned by Ionis ...
January 9, 2023, 9:24 am
Algernon pharmaceuticals announces phase 2b study of ifenprodil for chronic cough
Algernon pharmaceuticals Inc. (CSE:AGN, OTCQB:AGNPF) has announced that it is planning a 180-patient, 9...
January 9, 2023, 8:39 am
Crinetics pharmaceuticals to present corporate and clinical update at 41st annual j.p. morgan healthcare conference
Efforts to further increase commercial readiness ongoing as Phase 3 PATHFNDR trials of paltusotine in acromegaly approach topline data readouts which ...
January 9, 2023, 8:01 am
Astrazeneca to acquire cincor for us$1.8bn
AstraZeneca PLC (LSE:AZN) has announced it will acquire US-based biopharmaceutical firm CinCor for appr...
January 9, 2023, 7:09 am